WYOST

Google image searchProduct monograph

Active ingredient

denosumab, 120 MG/1.7 ML

DIN: 02545764

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: SANDOZ CANADA INCORPORATED

Date: 26-JUN-2024

ATC:

• M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
• M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
• M05BX — Other drugs affecting bone structure and mineralization (ATC, ATC/DDD)
• M05BX04 — DENOSUMAB (ATC/DDD)

Reference brand drug: Prolia, Xgeva

External Links for Wyost

Search on Google

• Wyost side effects
• Wyost dosage
• denosumab side effects
• denosumab dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find wyost photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.